Impact of vitamin D on proteinuria, insulin resistance, and cardiovascular parameters in kidney transplant recipients

Transplantation Proceedings

Volumn 43, Issue 10, 2011, Pages 3723-3729

  Lee, D R ^a,b   Kong, J M ^a   Cho, K I ^a   Chan, L ^b  

^a Maryknoll Hospital   (South Korea)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; STEROID; TACROLIMUS;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GRAFT RECIPIENT; HUMAN; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PULSE WAVE; VASODILATATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHI-SQUARE DISTRIBUTION; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; LIVING DONORS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARATHYROID HORMONE; PREVALENCE; PROTEINURIA; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASODILATION; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 83655182820     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.08.081     Document Type: Conference Paper

References (46)

1. National Kidney Foundation K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 2003 1
2. M.F. Holick Vitamin D deficiency N Engl J Med 357 2007 266
3. A.I. Jacob, A. Sallman, Z. Santz Defective photoproduction of cholecalciferol in normal and uremic humans J Nutr 114 1984 1313
4. R. Bouillon, G. Carmeliet, L. Verlinden Vitamin D and human health: lessons from vitamin D receptor null mice Endocr Rev 29 2008 726
5. K.A. Nibbelink, D.X. Tishkoff, S.D. Hershey 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte J Steroid Biochem Mol Biol 103 2007 533
6. J.R. Wu Wong, M. Nakane, J. Ma Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells Atherosclerosis 186 2006 20
7. J. Merke, P. Milde, S. Lewicka Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3 Studies in cultured bovine aortic endothelial cells and human dermal capillaries J Clin Invest 83 1989 1903
8. B. Maestro, N. Davila, M.C. Carranza Identification of a vitamin D response element in the human insulin receptor gene promoter J Steroid Biochem Mol Biol 84 2003 223
9. H. Dobnig, S. Pilz Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality Arch Intern Med 168 2008 1340
10. T.J. Wang, M.J. Penina, S.L. Booth Vitamin D and risk of cardiovascular disease Circulation 117 2008 503
11. M.L. Melamed, E.D. Michos, W. Post 25-Hydroxyvitamin D levels and the risk of mortality in the general population Arch Intern Med 168 2008 1629
12. R.D. Semba, D.K. Houston, S. Bandinelli Relationship of 25-hydroxyvitamin D with all cause and cardiovascular disease mortality in older community-dwelling adults Eur J Clin Nutr 64 2010 203
13. D.V. Barreto, F.C. Baretto, S. Liabeuf Vitamin D affects survival independently of vascular calcification in chronic kidney disease Clin J Am Soc Nephrol 4 2009 1128
14. R. Mehrotra, D.A. Kermah, I.B. Salusky Chronic kidney disease, hypovitaminosis D, and mortality in the United States Kidney Int 76 2009 931
15. P. Ravani, F. Malberti, G. Tripepi Vitamin D levels and patient outcome in chronic kidney disease Kidney Int 75 2009 88
16. M.L. Melamed, B. Astor, E.D. Michos 25-Hydroxyvitamin D levels, race, and the progression of kidney disease J Am Soc Nephrol 20 2009 2631
17. M. Wolf, A. Shah, O. Gutierrez Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int 72 2007 1004
18. A.Y. Wang, C.W. Lam, J.E. Sanderson Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study Am J Clin Nutr 87 2008 1631
19. C. Drechsler, M. Verduijn, S. Pilz Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study Nephrol Dial Transplant 26 3 2011 1024 1032
20. N.C. Boudville, A.B. Hodsman Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients Nephrol Dial Transplant 21 2006 2621
21. A. Stavroulopoulosa, M.J.D. Cassidya, C.J. Porter Vitamin D status in renal transplant recipients Am J Transplant 7 2007 2546
22. J. Lemann Jr, B.T. Doumas Proteinuria in health and disease assessed by measuring the urinary protein/creatinine ratio Clin Chem 33 1987 297
23. W. Kashif, N. Siddiqi, H.E. Dincer Proteinuria: How to evaluate an important finding Cleve Clin J Med 70 2003 535
24. I.H. De Boer, G.N. Ioannou, B. Kestenbaum 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 50 2007 69
25. H.H. Malluche, D.A. Goldstein, S.G. Massry Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome J Clin Invest 63 1979 494
26. S.G. Massry, D.A. Goldstein Calcium metabolism in patients with nephrotic syndrome: a state with vitamin D deficiency Am J Clin Nutr 31 1978 1572
27. D.A. Goldstein, Y. Oda, K. Kurokawa Blood levels of 25-hydroxyvitamin D in patients with nephrotic syndrome Ann Intern Med 87 1977 664
28. K. Kano, A. Nonoda, H. Yoneshida Serum concentrations of 25-hydroxyvitamin D and 24, 25-dihydroxyvitamin D in patients with various types of renal diseases Clin Nephrol 14 1980 274
29. M. Freundlich, Y. Quiroz, Z. Zhang Suppression of renin-angiotensin gene expression in the kidney by paricalcitol Kidney Int 74 2008 1394
30. A. Kuhlmann 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat Am J Physiol Renal Physiol 286 2004 526
31. R. Agarwal, M. Acharya, J. Tian Antiproteinuric effect of oral paricalcitol in chronic kidney disease Kidney Int 68 2005 2823
32. C. Szeto, K.M. Chow, B. Kwan Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial Am J Kidney Dis 51 2008 724
33. S. Fishbane, H. Chittineni, M. Packman Oral paricalcitol in the treatment of patients with CKD and proteinuric: a randomized trial Am J Kidney Dis 54 2009 647
34. P. Alborzi, N. Patel, C. Peterson Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double blind pilot trial Hypertension 52 2008 249
35. H.J. Lambers Heerspink, R. Agarwal, D.W. Coyne The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics Am J Nephrol 30 2009 280
36. A.W. Norman, J.B. Frankel, A.M. Heldt Vitamin D deficiency inhibits pancreatic secretion of insulin Science 209 1980 823
37. E. Liu, J.B. Meigs, A.G. Pittas Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults J Nutr 139 2009 329
38. C. Mathieu, C. Gysemans, A. Giulietti Vitamin D and diabetes Diabetologia 48 2005 1247
39. M. Chonchol, R. Scragg 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey Kidney Int 71 2007 134
40. A.G. Pittas, J. Lau, F.B. Hu Review: the role of vitamin D and calcium in type 2 diabetes A systematic review and meta-analysis J Clin Endocrinol Metab 92 2007 2017
41. C. Mattila, P. Knekt, S. Mnnistö Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes Diabetes Care 30 2007 2569
42. D.R. Matthews, J.P. Hosker, A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412
43. A. Zittermann, S. Schleithoff, R. Koerfer Vitamin D and vascular calcification Curr Opin Lipidol 18 2007 41
44. M.E. Safar, B.I. Levy, H. Struijker-Boudier Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors Curr Opin Nephrol Hypertens 10 2001 257
45. G.M. London, A.P. Guérin, F.H. Verbeke Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency J Am Soc Nephrol 18 2007 613
46. J.A. Sugden, J.I. Davies, M.D. Witham Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels Diabet Med 25 2008 320